The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Symbicort Turbohaler, 400 micrograms/12 micrograms/inhalation, inhalation powder



Merit Pharmaceuticals LimitedPPA23080/021/002

Main Information

Trade NameSymbicort Turbohaler, 400 micrograms/12 micrograms/inhalation, inhalation powder
Active SubstancesBudesonide dihydrate
Formoterol fumarate dihydrate
Dosage FormInhalation powder
Licence HolderMerit Pharmaceuticals Limited
Licence NumberPPA23080/021/002

Group Information

ATC CodeR03AK07 formoterol and budesonide

Status

License statusAuthorised
Licence Issued25/08/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back